Staphylokinase: a potent, uniquely fibrin-selective thrombolytic agent

被引:135
作者
Collen, D
机构
[1] Catholic Univ Louvain, Ctr Mol & Vasc Biol, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven VIB, Ctr Transgene Technol & Gene, B-3001 Leuven, Belgium
关键词
D O I
10.1038/nm0398-279
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Thrombosis, the blockage of blood vessels with dots, can lead to acute myocardial infarction and ischemia stroke both leading causes of death. Other than surgical interventions to remove or by pass the blockage or the generation of collateral vessels to provide a new blood supply, the only treatment available is the administration of thrombolytic agents to dissolve the blood clot. In this review, Desire Callen considers the properties and characteristics of staphylokinase that make it the thrombolytic agent of choice.
引用
收藏
页码:279 / 284
页数:6
相关论文
共 46 条
  • [1] CLONING AND EXPRESSION IN ESCHERICHIA-COLI, BACILLUS-SUBTILIS, AND STREPTOCOCCUS-SANGUIS OF A GENE FOR STAPHYLOKINASE - A BACTERIAL PLASMINOGEN-ACTIVATOR
    BEHNKE, D
    GERLACH, D
    [J]. MOLECULAR & GENERAL GENETICS, 1987, 210 (03): : 528 - 534
  • [2] One-year results from the global utilization of streptokinase and TPA for occluded coronary arteries (GUSTO-I) trial
    Califf, RM
    White, HD
    VandeWerf, EV
    Sadowski, Z
    Armstrong, PW
    Vahanian, A
    Simoons, ML
    Simes, RJ
    Lee, KL
    Topol, EJ
    [J]. CIRCULATION, 1996, 94 (06) : 1233 - 1238
  • [3] Selection of thrombolytic therapy for individual patients: Development of a clinical model
    Califf, RM
    Woodlief, LH
    Harrell, FE
    Lee, KL
    White, HD
    Guerci, A
    Barbash, GI
    Simes, RJ
    Weaver, WDD
    Simoons, ML
    Topol, EJ
    [J]. AMERICAN HEART JOURNAL, 1997, 133 (06) : 630 - 639
  • [5] Fibrin-selective thrombolytic therapy for acute myocardial infarction
    Collen, D
    [J]. CIRCULATION, 1996, 93 (05) : 857 - 865
  • [6] PRIMARY STRUCTURE AND GENE STRUCTURE OF STAPHYLOKINASE
    COLLEN, D
    ZHAO, ZA
    HOLVOET, P
    MARYNEN, P
    [J]. FIBRINOLYSIS, 1992, 6 (04) : 226 - 231
  • [7] Collen D, 1997, CIRCULATION, V95, P463
  • [8] Collen D, 1997, CIRCULATION, V95, P455
  • [9] Recombinant staphylokinase variants with altered immunoreactivity .1. Thrombolytic properties and antibody induction
    Collen, D
    Moreau, H
    Stockx, L
    Vanderschueren, S
    [J]. CIRCULATION, 1996, 94 (02) : 207 - 216
  • [10] MECHANISMS OF ACTIVATION OF MAMMALIAN PLASMA FIBRINOLYTIC SYSTEMS WITH STREPTOKINASE AND WITH RECOMBINANT STAPHYLOKINASE
    COLLEN, D
    VANHOEF, B
    SCHLOTT, B
    HARTMANN, M
    GUHRS, KH
    LIJNEN, HR
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 216 (01): : 307 - 314